Elizabeth J. Davis, MD

Associate Professor of Medicine
Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States

Presentation(s):

• Paper 31 - THE TETRAVALENT DEATH RECEPTOR 5 AGONIST OZEKIBART (INBRX-109) IN CHONDROSARCOMA: RESULTS FROM THE RANDOMIZED, REGISTRATIONAL, PHASE 2 CHONDRAGON STUDY

  Friday, November 14, 2025
  8:30 AM - 10:00 AM EST

  Disclosure information not submitted.